Skip to main content
. 2011 Dec 6;16(12):1752–1761. doi: 10.1634/theoncologist.2011-0029

Figure 4.

Figure 4.

Results of the sensitivity analysis without (A) and duplicating (B) reversal costs: expected net gain (ENG) for both the option to adopt and trial (ENGAT) and the option to delay and trial (ENGDT) for different sample sizes. The gray dotted line marks the optimal sample size (highest expected net gain). Abbreviations: ENG, expected net gain; ENGDT, ENG for the options to delay and trial; ENGAT, ENG for the options to adopt and trial.